Interventional cardiology devices are minimally invasive devices used in the detection and treatment of coronary artery disease. This report on interventional cardiology devices studies the current and future prospects of the market globally. The report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments included in the study. This section also provides the overall information and data analysis of the global interventional cardiology devices market with respect to the leading market segments based on type of device, technique, and geography.
The market overview section of the report comprises qualitative analysis of the overall interventional cardiology devices market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s Five Forces analysis and market attractiveness analysis. In addition, various analyses such as value chain analysis, regulatory framework, market attractiveness analysis by geography and competitive landscape by key players has also been provided. Value chain analysis includes the study of major steps involved in the production and distribution of interventional cardiology devices. Regulatory framework includes the study of different regulatory norms and procedures that regulate the approval and commercialization of interventional cardiology devices and techniques. The market attractiveness analysis is provided in order to explain the intensity of competition in the market in different geographies. The competitive scenario between different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help the market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.
The global interventional cardiology devices market has been segmented on the basis of device type, technique, and geography. Based on device type, the interventional cardiology devices market has been categorized into five major segments: stents, catheters, percutaneous transluminal coronary angioplasty (PTCA) balloons, percutaneous transluminal coronary angioplasty (PTCA) guide wires, and other accessories. Stents have been further categorized into three sub-segments: bare metal stents, drug eluting stents, and bio-absorbable stents. Catheters have been further categorized into angiography catheters, intravascular ultrasound (IVUS) catheters, percutaneous transluminal coronary angioplasty (PTCA) guiding catheters, and pulmonary artery catheters. Percutaneous transluminal coronary angioplasty (PTCA) balloons have been subdivided into normal balloons, cutting balloons, scoring balloons, and drug eluting balloons. The imaging systems interventional cardiology devices market is subdivided into intravascular ultrasound (IVUS) systems, fractional flow reserve (FFR) systems, and optical coherence tomography (OCT) systems. Market revenue in terms of USD million for the period between 2012 and 2022 along with the compound annual growth rate (CAGR %) from 2014 to 2022 are provided for all the segments, considering 2013 as the base year.
This exhaustive report includes 12 data tables and 33 figures to give readers a 360° view of The Interventional Cardiology Devices Market. Browse through this 118-page report to know what factors will shape the market during the period 2014-2022
Geographically, the interventional cardiology devices market has been categorized into six regions: North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World (RoW). North America comprises the U.S. and Canada. Europe comprises Germany, the U.K., and Rest of Europe. Asia-Pacific comprises China, India, and Rest of Asia-Pacific. Latin America comprises Brazil, Mexico, and Rest of Latin America. Middle East and North Africa comprises Saudi Arabia, the United Arab Emirates and Rest of MENA. The recommendations section included in the report would assist existing players to expanding their market share and new companies in establishing their presence in the interventional cardiology devices market. The report also profiles major players in the interventional cardiology devices market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Abbott Laboratories, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, Cordis Corporation, Medtronic, plc, St. Jude Medical, Inc., Smiths Medical, and Terumo Medical Corporation.
The global Interventional Cardiology Devices market is segmented as follows:
Global Interventional Cardiology Devices Market, by Device Type
Bare Metal Stents
Pulmonary Artery Catheters
Intravascular ultrasound (IVUS) Catheters
IVUS (intravascular ultrasound)
FFR (Fractional Flow Reserve)
OCT (Optical Coherence Tomography)
Percutaneous Transluminal Coronary Angioplasty Guidewires
Global Interventional Cardiology Devices Market, by Geography
Rest of Europe
Rest of Asia Pacific
Latin America (LATAM)
Rest of LATAM
Middle East North Africa (MENA)
United Arab Emirates
Rest of MENA
Rest of the World (RoW)
Request a sample of this report to know what opportunities will emerge in the rapidly evolving Interventional Cardiology Devices Market during 2014- 2022
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453